Font Size: a A A
Keyword [dual inhibitor]
Result: 1 - 20 | Page: 1 of 2
1. Design, Synthesis And Anti-tumor Activities Of Abl And Pi3k Dual Target Inhibitor
2. Study On Novel Acenaphtho-heterocycle Mcl-1/Bcl-2 Dual Inhibitors
3. Fragment-based Drug Design For Dual Inhibitor Of Cyclooxygenase-2and5-lipoxygenase
4. Scaffold Hopping Design, Synthesis, Antitumor Activity And Mechanism Of Evodiamine
5. Design, Synthesis And Anti-tumor Activity Evaluation Of Benzylpyrimidine Hydroxamic Acid Derivatives
6. Anti-tumor Activity Of CUDC-907, A Novel HDAC/PI3K Dual Inhibitor In Pancreatic Cancer
7. Design,Synthesis And Evaluation Of Novel A2A Inhibitors And Novel Hedgehog/PI3K Dual Inhibitors
8. Design, Synthesis And Antitumor Activity Of 2-aminothiazoles With VEGFR/PI3K As A Dual Target
9. Design,Synthesis And Bioactivity Activity Evaluation Of Novel Selective C-KIT/PDGFRα Dual Inhibitor For The Treatment Of Imatinib-resistant Gastrointestinal Stromal Tumors (GISTs)
10. Antitumor Activity And Mechanism Of Kinase Inhibitors C0129 And C0198
11. Antitumor Activity And Molecular Mechanism Of Action Of The PI3K And HDAC Dual Inhibitor CUDC-907 In Prostate Cancer
12. Design,Synthesis,Biological Evaluation And Molecular Modeling Of Novel 1H-pyrazolo[3,4-d] Pyrimidine Derivatives As BRAFV600E And VEGFR-2 Dual Inhibitors
13. Research On Anti-hepatoma Mechanism Of PI3K/mTOR Dual Inhibitor NVP-BEZ235
14. Anti-proliferative Effect Of PI3K/mTOR Dualinhibitor,PO-1023,is Synergistically Enhanced By Inhibition Of Neddylation In Human NSCLC A549 Cells
15. Cellular Effect And Mechanism Of Action Of A Novel-type PI3K/mTOR Dual Inhibitor,GDC-0084,on Cutaneous Squamous Cell Carcinoma(cSCC)
16. Design,Synthesis And Bioactivity Study Of Imidazo[4,5-c] Quinoline And β-Amino Alcohol Derivatives
17. Design And Synthesis Of Substituted Indole Compounds And Evaluation Of Their Anti-respiratory Syncytial Virus And Anti-influenza Virus Activities
18. Design,Synthesis And Preliminary Study Of Antitumor Activity Of Novel FLT3/VEGFR2 Dual Inhibitors
19. FGFR/VEGFR Dual Inhibitor: A Potential Targeted Therapy In Hepatocellular Carcinoma
20. Design,synthesis And Bioactivity Study Of Novel C-Met Inhibitors Based On Drug Resistance Reversal Strategy
  <<First  <Prev  Next>  Last>>  Jump to